We are live on ! Find out more
INVN

Invensense Inc
INVN

Delisted

INVN was delisted on the 17th of May, 2017.

185 hedge funds and large institutions have $1.48B invested in Invensense Inc in 2014 Q1 according to their latest regulatory filings, with 53 funds opening new positions, 52 increasing their positions, 65 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

77% more first-time investments, than exits

New positions opened: 53 | Existing positions closed: 30

20% more call options, than puts

Call options by funds: $117M | Put options by funds: $97.2M

13% more funds holding

Funds holding: 164185 (+21)

2% more capital invested

Capital invested by funds: $1.45B → $1.48B (+$27.4M)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

20% less repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 65

Holders
185
Holders Change
+21
Holders Change %
+12.8%
% of All Funds
5.34%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.09%
New
53
Increased
52
Reduced
65
Closed
30
Calls
$117M
Puts
$97.2M
Net Calls
+$19.4M
Net Calls Change
+$1.5M
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$233M -$34.6M -1,651,778 -14%
EAM
2
Eagle Asset Management
Florida
$108M -$16.8M -803,104 -15%
Vanguard Group
3
Vanguard Group
Pennsylvania
$95.7M +$12.1M +578,501 +17%
Lord, Abbett & Co
4
Lord, Abbett & Co
New Jersey
$81M +$23.8M +1,135,683 +50%
ORI
5
Oak Ridge Investments
Illinois
$64.4M +$1.59M +75,895 +3%
RIM
6
RS Investment Management
California
$58.7M -$25.7M -1,229,972 -33%
BIT
7
BlackRock Institutional Trust
California
$35.8M +$1.83M +87,333 +6%
BFA
8
BlackRock Fund Advisors
California
$34.4M +$504K +24,101 +2%
GIM
9
Granahan Investment Management
Massachusetts
$31.2M -$1.74M -83,000 -6%
RIM
10
Ranger Investment Management
Texas
$30.2M -$9.69M -463,020 -27%
CCM
11
Cadian Capital Management
New York
$25.8M -$16.8M -804,583 -42%
GH
12
GAM Holding
Switzerland
$24.8M +$6.63M +317,100 +43%
PCM
13
PAR Capital Management
Massachusetts
$23.5M -$3.07M -146,700 -13%
State Street
14
State Street
Massachusetts
$23.3M -$267K -12,783 -1%
EVM
15
Eaton Vance Management
Massachusetts
$22.9M -$10.2M -487,854 -34%
BSA
16
Braun Stacey Associates
New York
$21.5M -$749K -35,814 -4%
Barclays
17
Barclays
United Kingdom
$20.7M +$1.04M +49,646 +6%
Goldman Sachs
18
Goldman Sachs
New York
$20.5M +$6.45M +308,339 +55%
RA
19
Royce & Associates
New York
$19.3M -$5.38M -257,000 -24%
Bank of New York Mellon
20
Bank of New York Mellon
New York
$19.1M -$21.4M -1,021,099 -56%
T. Rowe Price Associates
21
T. Rowe Price Associates
Maryland
$19M +$1.29M +61,470 +8%
Northern Trust
22
Northern Trust
Illinois
$18M -$976K -46,639 -6%
Stifel Financial
23
Stifel Financial
Missouri
$17.9M +$15.8M +756,820 New
KCM
24
Kennedy Capital Management
Missouri
$17.8M -$4.24M -202,791 -21%
TSW
25
Thompson Siegel & Walmsley
Virginia
$17.7M -$386K -18,446 -2%

INVN Hedge Fund Activity: Q1 2014 in Review

185 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Invensense Inc (INVN) for Q1 2014, worth a combined $1.48B — up 1.9% from $1.45B a quarter earlier.

Buyers outnumbered sellers: 53 funds opened new INVN positions and 30 closed out — a net gain of 23 holders — while 52 added to existing stakes and 65 trimmed.

The largest buyer was Lord, Abbett & Co, adding an estimated $23.8M. The largest seller was Century Capital Management, exiting entirely with an estimated $39.1M sold.

  • 185 institutional investors held Invensense Inc (INVN) as of Q1 2014, up from 164 in Q4 2013.
  • Funds reported $1.48B of Invensense Inc stock for Q1 2014, up 1.9% quarter-over-quarter.
  • 53 funds opened new Invensense Inc positions in Q1 2014 and 30 closed out, a net change of +23 holders.
  • The largest Invensense Inc buyer in Q1 2014 was Lord, Abbett & Co, an estimated $23.8M added.
  • The largest Invensense Inc seller in Q1 2014 was Century Capital Management, an estimated $39.1M sold.

Based on aggregated 13F filings for Q1 2014.